Orforglipron Protocol Guide
Orforglipron is the first oral non-peptide GLP-1 receptor agonist, representing a breakthrough in weight loss research. Unlike injectable GLP-1 drugs, it is a small molecule that can be taken as a daily pill. It is studied for obesity and type 2 diabetes management.
Protocol Overview
- Compound
- Orforglipron (First Oral Small-Molecule GLP-1 Receptor Agonist)
- Category
- Oral Non-Peptide GLP-1 Agonist
- Vial Size
- 10mg (10mg tablet)
- Reconstitution
- N/A (oral tablet)
- Route
- Oral
- Frequency
- 7 days/week
Administration
Take orally with water. No reconstitution or injection required.
- Take with or without food (unless otherwise noted)
- Store at room temperature in a cool, dry place
- Follow the dosing schedule consistently
Administration Guidelines
- Take orally once daily on an empty stomach at least 30 minutes before first meal
- Start at 3mg daily and titrate up per protocol to target dose of 45mg
- Swallow tablet whole with water - do not crush or chew
- If a dose is missed skip it and resume next day at usual time
- Store tablets at room temperature in original packaging
- Protect from moisture and light
- Document administration times and observations
Storage Requirements
| State | Storage Conditions |
|---|---|
| Sealed container | Room temperature, cool dry place, protect from moisture |
| Opened container | Room temperature, keep sealed, use within 90 days |
Related Tools & Resources
Frequently Asked Questions
See the fact-checked Verified Dosing shown at the top of this page (verified against the FDA label / published trials); always confirm with a licensed provider.
Orforglipron is an oral tablet requiring no reconstitution. Take with water on an empty stomach at least 30 minutes before the first meal of the day.
Lyophilized (powder): Room temperature, cool dry place, protect from moisture. Reconstituted: Room temperature, keep sealed, use within 90 days.